Aurobindo Pharma Ltd
Aurobindo Pharma's GHG Emissions Data Preview
In 2025, Aurobindo Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Aurobindo Pharma has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind Aurobindo Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aurobindo Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Aurobindo Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Aurobindo Pharma amounted to 1,225,388 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Aurobindo Pharma increased by 26.66%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Aurobindo Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Aurobindo Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Aurobindo Pharma were 750,616 metric tons of CO₂ equivalent (tCO₂e). a
Has Aurobindo Pharma reduced its Scope 1 emissions over time?
Since 2019, Aurobindo Pharma's Scope 1 emissions have increased by 83.27%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Aurobindo Pharma's Scope 1 emissions increased by 81.15%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Aurobindo Pharma's Scope 2 emissions?
In 2025, Aurobindo Pharma reported Scope 2 greenhouse gas (GHG) emissions of 474,772 tCO₂e without specifying the calculation method. a
Has Aurobindo Pharma reduced its Scope 2 emissions over time?
Since 2019, Aurobindo Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Aurobindo Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2024), Aurobindo Pharma's Scope 2 emissions (Unspecified Calculation Method) fell by 14.16% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Aurobindo Pharma use for Scope 2 reporting?
In 2025, Aurobindo Pharma reported its Scope 2 emissions using an unspecified methodology. a
Aurobindo Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Aurobindo Pharma's Value Chain Emissions
In 2025, Aurobindo Pharma reported 360,221 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Aurobindo Pharma includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2024, reflecting improved emissions accounting practices and greater transparency across the company's value chain a
Aurobindo Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Aurobindo Pharma's Scope 3 emissions?
In 2025, Aurobindo Pharma reported total Scope 3 emissions of 360,221 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
What categories of Scope 3 emissions does Aurobindo Pharma disclose?
In 2025, Aurobindo Pharma reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Aurobindo Pharma's Scope 3 emissions?
In 2025, the largest contributors to Aurobindo Pharma's Scope 3 emissions were: a
- Fuel- and Energy-Related Services (Cat. 3): 246,964 tCO₂e (68.56%)
- Downstream Transportation and Distribution (Cat. 9): 70,698 tCO₂e (19.63%)
- Waste Generated in Operations (Cat. 5): 11,348 tCO₂e (3.15%)
Aurobindo Pharma's Scope 3 Emissions by Categories
Insights into Aurobindo Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Aurobindo Pharma reported Scope 1 greenhouse gas (GHG) emissions of 750,616 tCO₂e and total revenues of USD 3,672 millions. This translates into an emissions intensity of 204.39 tCO₂e per millions USD. a
Aurobindo Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Aurobindo Pharma's GHG emissions intensity compare to its peers?
In 2025, Aurobindo Pharma reported a Scope 1 emissions intensity of 204.39 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Aurobindo Pharma rank on GHG emissions intensity within its industry?
In 2025, Aurobindo Pharma ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Aurobindo Pharma among the least efficient performers, with one of the highest emissions intensities in its sector. a
Insights into Aurobindo Pharma's Total Carbon Footprint
In 2025, Aurobindo Pharma reported a total carbon footprint of 1,585,609 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 63.89% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Aurobindo Pharma's total carbon footprint was Scope 1 emissions, accounting for 47.34% of the company's total carbon footprint, followed by Scope 2 emissions at 29.94%. a